Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size
Uncategorised

Series A

Nura Bio navigates $73m series A
Nura Bio is working on neuroprotective treatments that exploit discoveries made at OHSU and UT Southwestern.
Daily deal net: July 30, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Bright Peak ascends to $35m series A
Drug protein discovery company Bright Peak hopes to deliver conjugated cancer immunotherapies based on an ETH Zürich-invented platform.
Enthera enters $32.8m series A round
Enthera Pharmaceuticals was co-founded by faculty from University of Milan and is using stem cells to treat autoimmune disorders.
MBX Biosciences extrapolates $34.6m
IU Philanthropic Venture Fund returned for a series A round expected to help MBX identify clinical-stage peptides for rare endocrine genetic diseases.
Tubulis bursts $12.5m
Tubulis has raised series A funding to progress an ADC development platform invented at Leibniz Research Institute and Ludwig Maximillians University.
Forge Biologics computes $40m series A
Forge is working on a gene therapy treatment invented at UPMC but has covered its bases by targeting viral vector production for third-party clients.
Daily deal net: July 23, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Other News

Mingdu Intelligent manufactures series A-plus funding
Mingdu Intelligent, backed by three Chinese academic institutions, has increased its funding haul to at least $26m.
Vesigen spawns with $28.5m series A
Vesigen has attracted Leaps by Bayer to commercialise drug delivery technology invented by Quan Lu at Harvard School of Public Health.
Dexterity has a knack for funding
Dexterity, a logistics robot spinout of Stanford, has emerged from stealth with series A funding and debt financing from Stanford-StartX Fund.
Mori reaps $12m series A
MIT and Tufts spinout Mori, which produces food preservatives using silk proteins, welcomed back The Engine for its series A round.
TileDB structures $15m series A
Based on joint research at MIT and Intel Labs, the data analytics engine provider has now raised $20m in all after a round featuring Intel Capital.
Daily deal net: July 14, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Editor's Picks

Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Big deal: NMD flexes series A muscles
Aarhus University spinout NMD Pharma, which focuses on therapies for neuromuscular conditions, has attracted the support of several corporates for its $47m series A round.
Immunocore smashes European biotech records
Immunotherapy firm Immunocore, which started life at Oxford University, raises the largest biotech round in European history.
Sphere Fluidics circles $2.5m
test reg

Login